Gene · 970
Papers4,349
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
261 to 280 of 4,349
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Ectopic PU.1 Expression Provides Chimeric Antigen Receptor (CAR) T Cells with Innate Cell Capacities Including IFN-β Release. | Cancers (Basel) | 2024 | 39123467 | PubTator, text mining | PubMed |
| 'Living drugs' target CD70 in advanced renal tumors. | Trends Pharmacol Sci | 2024 | 39079777 | PubTator, text mining | PubMed |
| Noninvasive prediction of CCL2 expression level in high-grade glioma patients. | Cancer Med | 2024 | 39030882 | PubTator, text mining | PubMed |
| CD70 identifies alloreactive T cells and represents a potential target for prevention and treatment of acute GVHD. | Blood Adv | 2024 | 39028952 | PubTator, text mining | PubMed |
| Coronavirus disease 2019-related myocarditis genes contribute to ECMO prognosis. | BMC Cardiovasc Disord | 2024 | 39026189 | PubTator, text mining | PubMed |
| CD28 Costimulation Augments CAR Signaling in NK Cells via the LCK/CD3ζ/ZAP70 Signaling Axis. | Cancer Discov | 2024 | 38900051 | PubTator, text mining | PubMed |
| Knocking Out CD70 Rescues CD70-Specific NanoCAR T Cells from Antigen-Induced Exhaustion. | Cancer Immunol Res | 2024 | 38874582 | PubTator, text mining | PubMed |
| Antibody drug conjugate, a level-up version of monoclonal antibody? | Int J Surg | 2024 | 38833359 | PubTator, text mining | PubMed |
| Single cells and TRUST4 reveal immunological features of the HFRS transcriptome. | Front Med (Lausanne) | 2024 | 38803345 | PubTator, text mining | PubMed |
| Re: CD70-Targeted Allogeneic CAR T-Cell Therapy for Advanced Clear Cell Renal Cell Carcinoma. | Eur Urol | 2024 | 38735819 | PubTator, text mining | PubMed |
| Expression of Potential Antibody-Drug Conjugate Targets in Cervical Cancer. | Cancers (Basel) | 2024 | 38730739 | PubTator, text mining | PubMed |
| The CD33xCD123xCD70 Multispecific CD3-Engaging DARPin MP0533 Induces Selective T Cell-Mediated Killing of AML Leukemic Stem Cells. | Cancer Immunol Res | 2024 | 38683145 | PubTator, text mining | PubMed |
| Primary immune regulatory disorders (PIRD): expanding the mutation spectrum in Turkey and identification of sixteen novel variants. | Immunol Res | 2024 | 38644452 | PubTator, text mining | PubMed |
| The development of chimeric antigen receptor T-cells against CD70 for renal cell carcinoma treatment. | J Transl Med | 2024 | 38637886 | PubTator, text mining | PubMed |
| Functional genomics identifies N-acetyllactosamine extension of complex N-glycans as a mechanism to evade lysis by natural killer cells. | Cell Rep | 2024 | 38619967 | PubTator, text mining | PubMed |
| Single-cell sequencing analysis and multiple machine-learning models revealed the cellular crosstalk of dendritic cells and identified FABP5 and KLRB1 as novel biomarkers for psoriasis. | Front Immunol | 2024 | 38596682 | PubTator, text mining | PubMed |
| CD70-Targeted Allogeneic CAR T-Cell Therapy for Advanced Clear Cell Renal Cell Carcinoma. | Cancer Discov | 2024 | 38583184 | PubTator, text mining | PubMed |
| CD70-specific CAR NK cells expressing IL-15 for the treatment of CD19-negative B-cell malignancy. | Blood Adv | 2024 | 38564778 | PubTator, text mining | PubMed |
| [Investigation of the immune profile of multiple myeloma patients achieving long-term survival after autologous stem cell transplantation]. | Zhonghua Nei Ke Za Zhi | 2024 | 38561281 | PubTator, text mining | PubMed |
| Comprehensive Immunogenomic Profiling of IDH1-/2-Altered Cholangiocarcinoma. | JCO Precis Oncol | 2024 | 38547421 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/970/papers?page=14